Eltrombopag for post-transplant cytopenias due to poor graft function-Reference-Cited by-同舟云学术

Eltrombopag for post-transplant cytopenias due to poor graft function

Published:2019-01-24 Issue:8 Volume:54 Page:1346-1353
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Marotta Serena,Marano Luana,Ricci Patrizia,Cacace Fabiana,Frieri Camilla,Simeone Luigia,Trastulli Fabio,Vitiello Selenia,Cardano Flora,Pane Fabrizio,Risitano Antonio M^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-019-0442-3.pdf

Reference38 articles.

1. Olsson R, Remberger M, Schaffer M, Berggren DM, Svahn BM, Mattsson J, et al. Graft failure in the modern era of allogeneic hematopoietic SCT. Bone Marrow Transplant. 2013;48:537–43. https://doi.org/10.1038/bmt.2012.239

2. Lee KH, Lee JH, Choi SJ, Lee JH, Kim S, Seol M, et al. Failure of trilineage blood cell reconstitution after initial neutrophil engraftment in patients undergoing allogeneic hematopoietic cell transplantation—frequency and outcomes. Bone Marrow Transplant. 2004;33:729–34. https://doi.org/10.1038/sj.bmt.1704428

3. Kong Y, Chang YJ, Wang YZ, Chen YH, Han W, Wang Y, et al. Association of an impaired bone marrow microenvironment with secondary poor graft function after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2013;19:1465–73. https://doi.org/10.1016/j.bbmt.2013.07.014

4. Dominietto A, Raiola AM, van Lint MT, Lamparelli T, Gualandi F, Berisso G, et al. Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: graft-versus-host disease, donor type, cytomegalovirus infections and cell dose. Br J Haematol. 2001;112:219–27.

5. Weaver CH, Hazelton B, Birch R, Palmer P, Allen C, Schwartzberg L, et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood. 1995;86:3961–9.

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombopoietin Receptor Agonists in Post-Hematopoietic Cell Transplantation Complicated by Prolonged Thrombocytopenia: A Comprehensive Review;ImmunoTargets and Therapy;2024-09

2. Aplasies médullaires sévères acquises dans les pays émergents : prise en charge dès l’indication de l’allogreffe de cellules souches hématopoïétiques jusqu’au suivi postgreffe (SFGM-TC);Bulletin du Cancer;2024-09

3. Treatment of post-allogeneic hematopoietic stem cell transplant cytopenias with sequential doses of multipotent mesenchymal stromal/stem cells;Cytotherapy;2024-08

4. Eltrombopag treatment in thrombocytopenia following hematopoietic stem cell transplantation: A multicenter real-world experience;Leukemia Research;2024-05

5. Eltrombopag can promote platelet implantation after allogeneic hematopoietic stem cell transplantation as safely and similarly to thrombopoietin;Frontiers in Immunology;2024-04-08